Skip to main content

COVID 19 Updates from RheumNow

Social

A randomized controlled trial testing dexamethasone for Covid-19 (the RECOVERY trial) showed that, compared with usual care, this corticosteroid drug reduced 28-day mortality in hospitalized patients. #COVID19 #SARSCoV2
1 year 1 month ago
#Texas we REALLY need to #WearAMaskSaveALife ... 6 patients of mine have tested positive for #COVID19 in the last week. #MedTwitter @rheum_covid @COVID19Tracking

Mohammad A. Ursani MD, RhMSUS @DrMAUrsani ( View Tweet )

1 year 1 month ago
RheumNow Podcast is Up! Listen to Fauci! Watch it here>> https://t.co/dHq3fP85Ip or Listen to the Podcast>> https://t.co/LdHO7fKUCp

Dr. John Cush @RheumNow ( View Tweet )

1 year 2 months ago
Regeneron/Sanofi have reported their US phase 3 trial of Kevzara (sarilumab) 400 mg given to 194 critically ill COVID-19 patients, requiring mechanical ventilation, did not meet its primary and key secondary endpoints when added to supportive care. https://t.co/UPfGJKWEM9

Dr. John Cush @RheumNow ( View Tweet )

1 year 2 months ago
The preliminary #ACR20 schedule is here! Along with all your favorite plenary and networking sessions, the program will feature #Rheumatologist Dr. Anthony Fauci giving us a live update on #COVID19. @ACRheum #ACRConvergence - Where Rheumatology Meets https://t.co/IWbiVw9PSP

Victoria Shanmugam @VickiShanmugam ( View Tweet )

1 year 2 months ago
NY Times Ranks COVID Rx Tracker: 1) Strong Evidence - Remdesivir, dexamethasone, Ventilation, Proning, anticoagulants; 2) Promising: convalescent plasma, Cytosorb, dialysis; 3) Mixed: IFN, Cytokine inhibitors, Stem Cells; 4) HCQ -not promising https://t.co/sbotsdYcg8

Dr. John Cush @RheumNow ( View Tweet )

1 year 2 months ago
Italian report of 2 cases (1 w/ stable RA;1 without prior arthritis) who developed polyarthritis after hospitalization for COVID pneumonia. Synovial Bx showed synovial proliferation - 1 w/ crystals and both w/ CD3+ and CD138+ cells https://t.co/ZRRrWIjZXg

Dr. John Cush @RheumNow ( View Tweet )

1 year 2 months ago
JAMA Internal Medicine reports that the number of hydroxychloroquine prescriptions increased from 367,346 to 683,999 (86.2%) from February to March 2020, and chloroquine prescriptions increased 158.6%, rising from 2,346 to 6,066 prescriptions. https://t.co/3MKsu5mOpx

Dr. John Cush @RheumNow ( View Tweet )

1 year 2 months ago
×